News|Articles|July 1, 2026

4 Nephrology Headlines You Missed in June 2026

Catch up on the nephrology headlines you missed in June 2026.

From evolving approaches to chronic kidney disease (CKD) management to new glomerular disease data and a regulatory update from the US Food and Drug Administration (FDA), June delivered several notable developments in nephrology.

Related to this article

Donald Cutlip, MD | Image Credit: BAIM Institute for Clinical Research

September 28th, 2026

Q&A: Cutlip on the SELUTION SLR DEB’s FDA Approval for Coronary In-Stent Restenosis

Donald Cutlip, MD, discusses the sirolimus balloon’s approval and its role in clinical practice for patients with ISR.

September 28th, 2026

Lessons From 10,000 Organ Transplants, With Ari Cohen, MD

Ochsner Transplant Institute director discusses liver transplant care, robotic kidney transplant, organ preservation, and access gaps.

September 26th, 2026

The HCPFive: Top News for Healthcare Providers from the Week of 09/20

Stay updated with the latest healthcare breakthroughs, including the FDA approval of insulin efsitora alfa-gobe (Onswik).

September 25th, 2026

FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata

Approval is based on 36-week data from BRAVE-AA-PEDS, in which 42% of patients on the 4 mg dose achieved a SALT score of 20 or less, compared with 5% on placebo.

Image Credit: US Food and Drug Administration

September 25th, 2026

Zilurgisertib Receives FDA Approval for FOP in Patients 12 and Older

The FDA approved once-daily oral zilurgisertib for FOP in patients aged 12 years and older after the phase 2 PROGRESS trial showed reduced new heterotopic ossification vs placebo.

September 25th, 2026

FDA Approves Obinutuzumab (Gazyva) for Idiopathic Nephrotic Syndrome

Approval covers patients aged ≥2 years with frequently relapsing or steroid dependent disease in complete remission.

September 25th, 2026

The Case for Routine Kidney Screening, With Pranav Garimella, MBBS, MPH

Pranav Garimella discusses what a potential USPSTF kidney screening recommendation could mean for high-risk adults and primary care.

September 24th, 2026

Nearly 9 in 10 US Adults With CKD Don't Know They Have It, With Pranav Garimella

As the USPSTF considers evidence for updated CKD screening guidance, Garimella discusses gaps in kidney disease detection and what the review should capture.